Dino Delaportas, MD
Infectious Disease · Bridgeport, WVNPI 1639124159
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $330,209 of the $478,093 with a category attached, or 69.1%. It is spread thinly across 31 manufacturers, the largest accounting for just 23.2%. Reporting peaked in 2019 at $204,950 and has fallen 94.0% since, to $12,198 in 2025. Among infectious disease clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 966 payments — averaging $494.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Melinta Therapeutics, LLC$111K
- AbbVie$107K
- Ferring Pharmaceuticals Inc.$87K
- Paratek Pharmaceuticals, Inc.$72K
- Cumberland Pharmaceuticals, Inc.$39K
- Merck$32K
- plus $30K from 25 others
Across 51 payments — averaging $5130.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$262K
What the payments were for
- Consulting fees$11,6642%
- Speaking & faculty fees$330,20969%
- Travel & lodging$113,63224%
- Food & beverage$21,0764%
- Education$1,5130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Melinta Therapeutics, LLC | 198 | $110,864 |
| AbbVie(2 entities) | 195 | $106,886 |
| Ferring Pharmaceuticals Inc. | 131 | $87,247 |
| Paratek Pharmaceuticals, Inc. | 142 | $71,619 |
| Cumberland Pharmaceuticals, Inc. | 78 | $39,425 |
| Merck | 77 | $31,881 |
| Insmed, Inc. | 64 | $24,079 |
| Shionogi Inc | 13 | $3,384 |
| Baudax Bio Inc. | 2 | $1,124 |
| Organogenesis Inc. | 10 | $292 |
| Smith+Nephew | 17 | $286 |
| La Jolla Pharmaceutical Company | 4 | $217 |
| Astellas Pharma US Inc | 5 | $171 |
| Lifenet Health | 5 | $113 |
| Accelerate Diagnostics Inc. | 2 | $69 |
| Bioventus LLC | 3 | $62 |
| Gilead | 4 | $61 |
| Misonix Inc | 3 | $55 |
| OVIK Health, LLC | 1 | $35 |
| Cipla USA Inc. | 1 | $35 |
| GRT US Holding, Inc. | 1 | $28 |
| Reprise Biomedical, Inc. | 1 | $23 |
| Invivyd Inc | 1 | $22 |
| Mylan Specialty L.p. | 1 | $19 |
| Hartmann USA, Inc. | 1 | $17 |
| Vyera Pharmaceuticals, LLC | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| GSK | 1 | $14 |
| Mckesson Patient Care Solutions Inc. | 1 | $12 |
| Kerecis Limited | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$478,093 in reported general payments places this provider in the 95th percentile of 39 infectious disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rifampin | 34 | $3,741 |
| Vancomycin Hcl | 11 | $1,295 |
| Dicloxacillin Sodium | 22 | $1,263 |
| CeftriaxoneCeftriaxone Sodium | 12 | $1,037 |
| Amoxicillin | 19 | $594 |
| Doxycycline Hyclate | 30 | $493 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $369 |
| Fluconazole | 18 | $128 |
| Ciprofloxacin Hcl | 16 | $101 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Bridgeport
- Badiaa El-ImadBridgeport$618
- Jonathan StanleyBridgeport$68
- Zonaira GulBeckley$2K
- Archana VasudevanMorgantown$1K
- Leeja JosephHuntington$517
- Theresa HysellHuntington$486
- Mahmoud ShormanHuntington$482
- Rashida KhakooMorgantown$246
- Kara WillenburgHuntington$222
- Taras NebelukCharleston$187
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.